Experiences of continuous infusion of B-domain deleted recombinant factor VIII (ReFacto®) for major surgery.

被引：0
|
作者：
Schulman, S
Roussel-Robert, V
Stieltjes, N
Negrier, C
Reynaud, J
Villar, A
Pouzol, P
Savidge, GF
Altisent, C
Auerswald, G
机构：
[1] Karolinska Hosp, S-10401 Stockholm, Sweden
[2] Hop Cochin, F-75674 Paris, France
[3] Hop Edouard Herriot, Lyon, France
[4] Hop Nord St Etienne, St Etienne, France
[5] Hosp La Paz, Madrid, Spain
[6] Hop Robert Debre, Reims, France
[7] St Thomas Hosp, London, England
[8] Vall Hebron, Barcelona, Spain
[9] Zentralkrankenhaus St Jurgen Str, Bremen, Germany
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3920
引用
收藏
页码：111B / 111B
页数：1
相关论文
共 50 条
  • [21] FUNCTIONAL-CHARACTERISTICS OF A NEW RECOMBINANT FACTOR-VIII WITH A DELETED B-DOMAIN R-VIII SQ
    SANDBERG, H
    SEBRING, S
    ALMSTEDT, A
    BRANDT, J
    OSWALDSSON, U
    SANDBERG, M
    PERSSON, P
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1204 - 1204
  • [22] The safety and efficacy of B-domain deleted recombinant factor VIII concentrates in patients with severe haemophilia A: an update
    Lusher, JM
    Roth, DA
    HAEMOPHILIA, 2005, 11 (03) : 292 - 293
  • [23] Use of B-domain deleted recombinant factor VIII (BDDrFVIII) in the surgical management of patients with hemophilia.
    Hay, AC
    Berntorp, E
    White, G
    Rodriguez, D
    Bedrosian, C
    BLOOD, 1999, 94 (10) : 236A - 236A
  • [24] A pharmacovigilance evaluation of B-Domain deleted recombinant factor VIII - interim results after 9 years
    Pollmann, H.
    Westfeld, M.
    Eifrig, B.
    Klamroth, R.
    Kreuz, W.
    Lenk, H.
    Oldenburg, J.
    Pabinger, I
    Schramm, W.
    Schwarz, T.
    Zavazava, N.
    Zimmermann, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 827 - 828
  • [25] Pharmacokinetics of the reformulated B-domain deleted recombinant factor VIII concentrate using chromogenicand one-stage assays with pooled normal plasma and refacto laboratory standard
    Santoro, C.
    Mazzucconi, M. G.
    Pignoloni, P.
    Rago, A.
    Biondo, E.
    Iorio, A.
    Ferrante, F.
    Torelli, F.
    Agnelli, G.
    Foa, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 33 - 33
  • [26] Addition of short fragments of the B-domain eliminates the discrepancy of factor VIII activity of B-domain deleted factor VIII between clotting and chromogenic assays
    Aburubaiha, Z.
    Srour, M.
    Oldenburg, J.
    Schwaab, R.
    HAEMOPHILIA, 2012, 18 : 107 - 107
  • [27] Recombinant, B-domain deleted factor VIII (r-VIII SQ): Pharmacokinetics and initial safety aspects in hemophilia A patients
    Fijnvandraat, K
    Berntorp, E
    tenCate, JW
    Johnsson, H
    Peters, M
    Savidge, G
    Tengborn, L
    Spira, J
    Stahl, C
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (02) : 298 - 302
  • [28] PHARMACOKINETICS AND PHARMACODYNAMICS OF A B-DOMAIN DELETED RECOMBINANT FACTOR-VIII DERIVATIVE, R-VIII SQ, IN CANINE HEMOPHILIA
    BRINKHOUS, KM
    WIDLUND, L
    READ, MS
    SIGMAN, JL
    OSWALDSSON, U
    BRANDT, J
    SANDBERG, H
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 852 - 852
  • [29] Meta-analysis on the effectiveness of B-domain deleted factor VIII for prophylaxis
    van der Bom, JG
    Fischer, K
    van den Berg, HM
    HAEMOPHILIA, 2003, 9 (06) : 744 - 744
  • [30] Routine prophylaxis treatment in previously treated patients (PTPs) with B-domain deleted recombinant factor VIII (BDDrFVIII).
    Lusher, JM
    Kessler, CM
    White, GC
    Bedrosian, CL
    Magill, M
    Nissen, S
    Nguyen, K
    BLOOD, 2001, 98 (11) : 40A - 40A
12345